Pre-order Enquiry
Request Free Sample
Global and Japan Synthetic Lethality-based Drugs and Targets Market Size, Status and Forecast 2021-2027
SKU ID : QYR-19051417 | Publishing Date : 31-Aug-2021 | No. of pages : 105
Detailed TOC of Global and Japan Synthetic Lethality-based Drugs and Targets Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global Synthetic Lethality-based Drugs and Targets Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Medical Research Institution
1.3.3 Hospital and Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Synthetic Lethality-based Drugs and Targets Market Perspective (2016-2027)
2.2 Synthetic Lethality-based Drugs and Targets Growth Trends by Regions
2.2.1 Synthetic Lethality-based Drugs and Targets Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Synthetic Lethality-based Drugs and Targets Historic Market Share by Regions (2016-2021)
2.2.3 Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Regions (2022-2027)
2.3 Synthetic Lethality-based Drugs and Targets Industry Dynamic
2.3.1 Synthetic Lethality-based Drugs and Targets Market Trends
2.3.2 Synthetic Lethality-based Drugs and Targets Market Drivers
2.3.3 Synthetic Lethality-based Drugs and Targets Market Challenges
2.3.4 Synthetic Lethality-based Drugs and Targets Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Synthetic Lethality-based Drugs and Targets Players by Revenue
3.1.1 Global Top Synthetic Lethality-based Drugs and Targets Players by Revenue (2016-2021)
3.1.2 Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Players (2016-2021)
3.2 Global Synthetic Lethality-based Drugs and Targets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Synthetic Lethality-based Drugs and Targets Revenue
3.4 Global Synthetic Lethality-based Drugs and Targets Market Concentration Ratio
3.4.1 Global Synthetic Lethality-based Drugs and Targets Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Synthetic Lethality-based Drugs and Targets Revenue in 2020
3.5 Synthetic Lethality-based Drugs and Targets Key Players Head office and Area Served
3.6 Key Players Synthetic Lethality-based Drugs and Targets Product Solution and Service
3.7 Date of Enter into Synthetic Lethality-based Drugs and Targets Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Synthetic Lethality-based Drugs and Targets Breakdown Data by Type
4.1 Global Synthetic Lethality-based Drugs and Targets Historic Market Size by Type (2016-2021)
4.2 Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Type (2022-2027)
5 Synthetic Lethality-based Drugs and Targets Breakdown Data by Application
5.1 Global Synthetic Lethality-based Drugs and Targets Historic Market Size by Application (2016-2021)
5.2 Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Synthetic Lethality-based Drugs and Targets Market Size (2016-2027)
6.2 North America Synthetic Lethality-based Drugs and Targets Market Size by Type
6.2.1 North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021)
6.2.2 North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027)
6.2.3 North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2027)
6.3 North America Synthetic Lethality-based Drugs and Targets Market Size by Application
6.3.1 North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021)
6.3.2 North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027)
6.3.3 North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2027)
6.4 North America Synthetic Lethality-based Drugs and Targets Market Size by Country
6.4.1 North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021)
6.4.2 North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Synthetic Lethality-based Drugs and Targets Market Size (2016-2027)
7.2 Europe Synthetic Lethality-based Drugs and Targets Market Size by Type
7.2.1 Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021)
7.2.2 Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027)
7.2.3 Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2027)
7.3 Europe Synthetic Lethality-based Drugs and Targets Market Size by Application
7.3.1 Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021)
7.3.2 Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027)
7.3.3 Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2027)
7.4 Europe Synthetic Lethality-based Drugs and Targets Market Size by Country
7.4.1 Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021)
7.4.2 Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size (2016-2027)
8.2 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type
8.2.1 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2027)
8.3 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application
8.3.1 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2027)
8.4 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region
8.4.1 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Synthetic Lethality-based Drugs and Targets Market Size (2016-2027)
9.2 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type
9.2.1 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021)
9.2.2 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027)
9.2.3 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2027)
9.3 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application
9.3.1 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021)
9.3.2 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027)
9.3.3 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2027)
9.4 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country
9.4.1 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021)
9.4.2 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size (2016-2027)
10.2 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Type
10.2.1 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2027)
10.3 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Application
10.3.1 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2027)
10.4 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country
10.4.1 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Synthetic Lethality-based Drugs and Targets Introduction
11.1.4 AbbVie Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Synthetic Lethality-based Drugs and Targets Introduction
11.2.4 AstraZeneca Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 BeiGene
11.3.1 BeiGene Company Details
11.3.2 BeiGene Business Overview
11.3.3 BeiGene Synthetic Lethality-based Drugs and Targets Introduction
11.3.4 BeiGene Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.3.5 BeiGene Recent Development
11.4 Clovis Oncology
11.4.1 Clovis Oncology Company Details
11.4.2 Clovis Oncology Business Overview
11.4.3 Clovis Oncology Synthetic Lethality-based Drugs and Targets Introduction
11.4.4 Clovis Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.4.5 Clovis Oncology Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Introduction
11.5.4 GlaxoSmithKline Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Synthetic Lethality-based Drugs and Targets Introduction
11.6.4 Pfizer Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 AtlasMedx
11.7.1 AtlasMedx Company Details
11.7.2 AtlasMedx Business Overview
11.7.3 AtlasMedx Synthetic Lethality-based Drugs and Targets Introduction
11.7.4 AtlasMedx Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.7.5 AtlasMedx Recent Development
11.8 Chordia Therapeutics
11.8.1 Chordia Therapeutics Company Details
11.8.2 Chordia Therapeutics Business Overview
11.8.3 Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Introduction
11.8.4 Chordia Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.8.5 Chordia Therapeutics Recent Development
11.9 IDEAYA Biosciences
11.9.1 IDEAYA Biosciences Company Details
11.9.2 IDEAYA Biosciences Business Overview
11.9.3 IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Introduction
11.9.4 IDEAYA Biosciences Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.9.5 IDEAYA Biosciences Recent Development
11.10 Mission Therapeutics
11.10.1 Mission Therapeutics Company Details
11.10.2 Mission Therapeutics Business Overview
11.10.3 Mission Therapeutics Synthetic Lethality-based Drugs and Targets Introduction
11.10.4 Mission Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.10.5 Mission Therapeutics Recent Development
11.11 Repare Therapeutics
11.11.1 Repare Therapeutics Company Details
11.11.2 Repare Therapeutics Business Overview
11.11.3 Repare Therapeutics Synthetic Lethality-based Drugs and Targets Introduction
11.11.4 Repare Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.11.5 Repare Therapeutics Recent Development
11.12 Sierra Oncology
11.12.1 Sierra Oncology Company Details
11.12.2 Sierra Oncology Business Overview
11.12.3 Sierra Oncology Synthetic Lethality-based Drugs and Targets Introduction
11.12.4 Sierra Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.12.5 Sierra Oncology Recent Development
11.13 SyntheX Labs
11.13.1 SyntheX Labs Company Details
11.13.2 SyntheX Labs Business Overview
11.13.3 SyntheX Labs Synthetic Lethality-based Drugs and Targets Introduction
11.13.4 SyntheX Labs Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.13.5 SyntheX Labs Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global and Japan Synthetic Lethality-based Drugs and Targets Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monotherapy
Table 3. Key Players of Combination Therapy
Table 4. Global Synthetic Lethality-based Drugs and Targets Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Synthetic Lethality-based Drugs and Targets Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Synthetic Lethality-based Drugs and Targets Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Synthetic Lethality-based Drugs and Targets Market Share by Regions (2016-2021)
Table 8. Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Synthetic Lethality-based Drugs and Targets Market Share by Regions (2022-2027)
Table 10. Synthetic Lethality-based Drugs and Targets Market Trends
Table 11. Synthetic Lethality-based Drugs and Targets Market Drivers
Table 12. Synthetic Lethality-based Drugs and Targets Market Challenges
Table 13. Synthetic Lethality-based Drugs and Targets Market Restraints
Table 14. Global Synthetic Lethality-based Drugs and Targets Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Synthetic Lethality-based Drugs and Targets Market Share by Players (2016-2021)
Table 16. Global Top Synthetic Lethality-based Drugs and Targets Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Synthetic Lethality-based Drugs and Targets as of 2020)
Table 17. Ranking of Global Top Synthetic Lethality-based Drugs and Targets Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Synthetic Lethality-based Drugs and Targets Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Synthetic Lethality-based Drugs and Targets Product Solution and Service
Table 21. Date of Enter into Synthetic Lethality-based Drugs and Targets Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Type (2016-2021)
Table 25. Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Synthetic Lethality-based Drugs and Targets Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Application (2016-2021)
Table 29. Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027) & (US$ Million)
Table 61. AbbVie Company Details
Table 62. AbbVie Business Overview
Table 63. AbbVie Synthetic Lethality-based Drugs and Targets Product
Table 64. AbbVie Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 65. AbbVie Recent Development
Table 66. AstraZeneca Company Details
Table 67. AstraZeneca Business Overview
Table 68. AstraZeneca Synthetic Lethality-based Drugs and Targets Product
Table 69. AstraZeneca Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 70. AstraZeneca Recent Development
Table 71. BeiGene Company Details
Table 72. BeiGene Business Overview
Table 73. BeiGene Synthetic Lethality-based Drugs and Targets Product
Table 74. BeiGene Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 75. BeiGene Recent Development
Table 76. Clovis Oncology Company Details
Table 77. Clovis Oncology Business Overview
Table 78. Clovis Oncology Synthetic Lethality-based Drugs and Targets Product
Table 79. Clovis Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 80. Clovis Oncology Recent Development
Table 81. GlaxoSmithKline Company Details
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Product
Table 84. GlaxoSmithKline Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 85. GlaxoSmithKline Recent Development
Table 86. Pfizer Company Details
Table 87. Pfizer Business Overview
Table 88. Pfizer Synthetic Lethality-based Drugs and Targets Product
Table 89. Pfizer Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 90. Pfizer Recent Development
Table 91. AtlasMedx Company Details
Table 92. AtlasMedx Business Overview
Table 93. AtlasMedx Synthetic Lethality-based Drugs and Targets Product
Table 94. AtlasMedx Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 95. AtlasMedx Recent Development
Table 96. Chordia Therapeutics Company Details
Table 97. Chordia Therapeutics Business Overview
Table 98. Chordia Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 99. Chordia Therapeutics Recent Development
Table 100. IDEAYA Biosciences Company Details
Table 101. IDEAYA Biosciences Business Overview
Table 102. IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Product
Table 103. IDEAYA Biosciences Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 104. IDEAYA Biosciences Recent Development
Table 105. Mission Therapeutics Company Details
Table 106. Mission Therapeutics Business Overview
Table 107. Mission Therapeutics Synthetic Lethality-based Drugs and Targets Product
Table 108. Mission Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 109. Mission Therapeutics Recent Development
Table 110. Repare Therapeutics Company Details
Table 111. Repare Therapeutics Business Overview
Table 112. Repare Therapeutics Synthetic Lethality-based Drugs and Targets Product
Table 113. Repare Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 114. Repare Therapeutics Recent Development
Table 115. Sierra Oncology Company Details
Table 116. Sierra Oncology Business Overview
Table 117. Sierra Oncology Synthetic Lethality-based Drugs and Targets Product
Table 118. Sierra Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 119. Sierra Oncology Recent Development
Table 120. SyntheX Labs Company Details
Table 121. SyntheX Labs Business Overview
Table 122. SyntheX Labs Synthetic Lethality-based Drugs and Targets Product
Table 123. SyntheX Labs Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 124. SyntheX Labs Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Synthetic Lethality-based Drugs and Targets Market Share by Type: 2020 VS 2027
Figure 2. Monotherapy Features
Figure 3. Combination Therapy Features
Figure 4. Global Synthetic Lethality-based Drugs and Targets Market Share by Application: 2020 VS 2027
Figure 5. Medical Research Institution Case Studies
Figure 6. Hospital and Clinic Case Studies
Figure 7. Other Case Studies
Figure 8. Synthetic Lethality-based Drugs and Targets Report Years Considered
Figure 9. Global Synthetic Lethality-based Drugs and Targets Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Synthetic Lethality-based Drugs and Targets Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Synthetic Lethality-based Drugs and Targets Market Share by Regions: 2020 VS 2027
Figure 12. Global Synthetic Lethality-based Drugs and Targets Market Share by Regions (2022-2027)
Figure 13. Global Synthetic Lethality-based Drugs and Targets Market Share by Players in 2020
Figure 14. Global Top Synthetic Lethality-based Drugs and Targets Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Synthetic Lethality-based Drugs and Targets as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Synthetic Lethality-based Drugs and Targets Revenue in 2020
Figure 16. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Type (2016-2021)
Figure 17. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Type (2022-2027)
Figure 18. North America Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Synthetic Lethality-based Drugs and Targets Market Share by Type (2016-2027)
Figure 20. North America Synthetic Lethality-based Drugs and Targets Market Share by Application (2016-2027)
Figure 21. North America Synthetic Lethality-based Drugs and Targets Market Share by Country (2016-2027)
Figure 22. United States Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Synthetic Lethality-based Drugs and Targets Market Share by Type (2016-2027)
Figure 26. Europe Synthetic Lethality-based Drugs and Targets Market Share by Application (2016-2027)
Figure 27. Europe Synthetic Lethality-based Drugs and Targets Market Share by Country (2016-2027)
Figure 28. Germany Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Share by Region (2016-2027)
Figure 38. China Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Synthetic Lethality-based Drugs and Targets Market Share by Type (2016-2027)
Figure 46. Latin America Synthetic Lethality-based Drugs and Targets Market Share by Application (2016-2027)
Figure 47. Latin America Synthetic Lethality-based Drugs and Targets Market Share by Country (2016-2027)
Figure 48. Mexico Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Share by Country (2016-2027)
Figure 54. Turkey Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. AbbVie Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
Figure 58. AstraZeneca Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
Figure 59. BeiGene Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
Figure 60. Clovis Oncology Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
Figure 63. AtlasMedx Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
Figure 64. Chordia Therapeutics Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
Figure 65. IDEAYA Biosciences Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
Figure 66. Mission Therapeutics Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
Figure 67. Repare Therapeutics Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
Figure 68. Sierra Oncology Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
Figure 69. SyntheX Labs Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Keyplayers in Global and Japan Synthetic Lethality-based Drugs and Targets Market Size, Status and Forecast 2021-2027
AbbVieAstraZeneca
BeiGene
Clovis Oncology
GlaxoSmithKline
Pfizer
AtlasMedx
Chordia Therapeutics
IDEAYA Biosciences
Mission Therapeutics
Repare Therapeutics
Sierra Oncology
SyntheX Labs
Request Sample
Request Discount
